Abstract:At present, the factors influencing Tuberculosis (TB) treatment effectiveness in HIV/TB co-infected patients need to be supported by more substantial real-world evidence. A retrospective study is conducted to fill the vacancy. 461 TB patients with HIV are defined as 742 samples according to each TB detection period. 7788 valid treatment records corresponding to 17 drug compositions for TB and 150 clinical indicators with more than 100 records are used to conduct data mining with consensus clustering, Fisher’s exact test, stratified analysis, and three modeling approaches, including logistic regression, support vector machine, and random forest. We find that A CD4+ T cell count of 42 cells per μL may serve as a sensitive classification standard for the immune level to assist in evaluating or predicting the efficacy of TB ( P =0.007); Rifabutin and levofloxacin alone or in combination may be more effective than other first- and second-line anti-TB agents in combination ( P =0.037); Samples with low immune levels (CD4≦42) may be more resistant to first-line TB drugs ( P =0.049); Age ( P =0.015), bicarbonate radical ( P =0.007), high-density lipoprotein cholesterol ( P =0.026), pre-treatment CD8+ T cell count ( P =0.015, age<60, male), neutrophil percentage ( P =0.033, age<60), rifabutin ( P =0.010, age<60), and cycloserine ( P =0.027, age<60) may influence the TB treatment effectiveness; More evidence is needed to support the relationship between pre-treatment clinical indicators or drug regimens and TB treatment effectiveness (The best AUC is 0.560∼0.763); The percentage of lymphocytes ( P =0.028) can be used as an effective TB therapeutic target. These perspectives supplement knowledge in relevant clinical aspects. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was funded by Funds for the key project of the Shanghai Public Health Clinical Center (KY-GW-2023-15); Shanghai Science and Technology Commission Medical Innovation Research Special Major Project (21Y31900400); Shanghai Science and Technology Commission Shanghai infectious diseases (AIDS) Clinical Medical Research Center Project (20MC1920100); Shenkang Hospital Development Center Clinical Science and Technology Innovation Project (SHDC22021317); Shanghai Municipal Science and Technology Critical Special Project "Research on Key Technologies for Prevention and Control of Major Sudden Infectious Diseases" (ZD2021CY001); Shenkang Hospital Development Center Clinical Research Basic Support Project (SHDC2020CR6025). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics Committee of Shanghai Public Clinical Center(No. 2020-S110-01) gave ethical approval for this work I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present study are available upon reasonable request to the authors

The yield of tuberculosis contact investigation on relapsed TB patients and analysis of associated risk factors: Singapore's experience

The yield of tuberculosis contact investigation in São Paulo, Brazil: a community-based cross-sectional study

Singapore tuberculosis (TB) clinical management guidelines 2024: A modified Delphi adaptation of international guidelines for drug-susceptible TB infection and pulmonary disease

Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016

Examining the social status, risk factors and lifestyle changes of tuberculosis patients in Sri Lanka during the treatment period: a cross-sectional study

A Whole-Genome Sequencing-Based Study to Delineate the Risk and Characteristics of Tuberculosis Transmission in an Insular Population Over 10 Years in Shanghai

Contact Investigation of Tuberculosis in Shanghai, China: A 13-Year Cohort

Social-behavioral insights in understanding tuberculosis transmission pattern during the COVID-19 pandemic period in Kuala Lumpur, Malaysia: The MyTBNet study protocol

An evaluation of tuberculosis contact investigations against national standards

Household Contact Screening and Yield of Tuberculosis Cases—A Clinic Based Study in Chennai, South India

Tuberculosis in Hong Kong-patient characteristics and treatment outcome

The Yield of Active Tuberculosis Disease and Latent Tuberculosis Infection in Tuberculosis Household Contacts Investigated Using Chest X-ray in Yogyakarta Province, Indonesia

Latent Tuberculosis Infection and Associated Risk Factors among the Tuberculosis Contacts in One of District in Shanghai

Use of the T-SPOT.TB Assay to Screen Latent Tuberculosis Infection among the TB Contacts in Shanghai, China.

Preventability of incident cases of tuberculosis in recently exposed contacts

The Study of Tuberculosis Outbreak in a High School—shanghai, China, 2017–2018

Role of Casual Contacts in the Recent Transmission of Tuberculosis in Settings with High Disease Burden.

Assessment of Tuberculosis Contact Investigation in Shanghai, China: an 8-Year Cohort Study.

A Retroactive Study on Factors Influencing the Efficacy of Treatment for Tuberculosis Patients with HIV: based on the data from 2010 to 2020 in Shanghai, China

Yield of Tuberculosis Contact Screening and Predictors of Contact Tuberculosis Diagnosis in Bungoma County Hospital, Kenya

High Incidence and Low Case Detection Rate among Contacts of Tuberculosis Cases in Shanghai, China.